S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ABVC ABVC BioPharma Inc

0.785

-0.073 (-8.51%)

May 31 2024 - Closed

Delayed by 15 minutes

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

ABVC BioPharma (NASDAQ:ABVC)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more ABVC BioPharma Charts.

ABVC BioPharma (NASDAQ:ABVC)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more ABVC BioPharma Charts.

ABVC BioPharma Inc News

Form 8-K - Current report
Friday 24 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Thursday 23 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Wednesday 22 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Wednesday 22 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Friday 17 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 17 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Wednesday 15 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (3 weeks ago) • Edgar (US Regulatory)

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Thursday 18 April 2024 (1 month ago) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Wednesday 17 April 2024 (1 month ago) • GlobeNewswire Inc.

More ABVC BioPharma Inc News Articles

Rep Fse Oat/strip10 23ff

Invesco S&P 500 Equal We...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions